Skip to content
Buy This GLP
← Research
Evidence

Can You Switch From Semaglutide to Tirzepatide?

A short switch study and a matched type 2 diabetes cohort answer different questions about weight and blood sugar after prior GLP-1 use.

Editorial profile: Neil SandersBuy This GLP Editorial Team4 min read
Weight lost at twelve months, kilogramstirzepatide, no recent use10.2semaglutide, no recent use6.1tirzepatide, used one before7.9semaglutide, used one before3.7Adults with type 2 diabetes and two recorded weights.

A prescriber can consider switching from semaglutide to tirzepatide when tirzepatide is appropriate for the condition being treated. The U.S. prescribing information for Zepbound advises against combining it with a GLP-1 receptor agonist such as semaglutide [3]. The prescriber can plan the change around the current product, side effects and other medicines.

What a prospective switch study found

The evidence on switching in the reverse direction comes from different studies. In a prospective 12-week study of 152 adults with type 2 diabetes, participants changed from a stable GLP-1 prescription to tirzepatide. Prior medicines included injectable semaglutide, dulaglutide and liraglutide [2].

Mean HbA1c declined by 0.43 percentage points and weight by 2.15 kg at week 12. These were overall changes from baseline across the prior medicines. The study did not include a group continuing semaglutide, so it cannot show how much of the change the switch itself added [2].

How prior use changed the comparison

In a separate observational study of people with type 2 diabetes, researchers checked for GLP-1 prescription fills in the previous six months. Those with prior fills lost 7.9 kg after starting tirzepatide and 3.7 kg after starting injectable semaglutide at 12 months. The corresponding changes among people without fills in that period were 10.2 kg and 6.1 kg [1].

The weight results used participants with both baseline and follow-up measurements. In the prior-use groups, that meant 296 on tirzepatide and 224 on semaglutide out of 5,577 matched participants per group. In the groups without prior use, 454 and 432 participants had both weights out of 10,702 per group [1].

What to discuss before a change

The GLP-1 insurance guide explains how coverage can depend on the product and diagnosis. If cost or availability is the issue, check coverage for the proposed prescription. Your prescriber can review your response, side effects and whether other diabetes medicines need closer monitoring[3].

Frequently asked

Can you switch from semaglutide to tirzepatide?
A prescriber can consider switching if tirzepatide fits your treatment goals and medical history. The Zepbound label advises against combining it with a GLP-1 medicine such as semaglutide.
How much weight can you lose after switching?
In one uncontrolled 12-week study of adults with type 2 diabetes changing from several GLP-1 medicines to tirzepatide, average weight fell 2.15 kg. That result cannot predict individual weight loss after switching from semaglutide.

Sources

  1. [1] Hoog MM, et al. (2025). Real-World Effectiveness of Tirzepatide versus Semaglutide on HbA1c and Weight in Patients with Type 2 Diabetes Diabetes Therapy. PMID 41066072
  2. [2] Jabbour S, Paik JS, Aleppo G, et al. (2024). Switching to Tirzepatide 5 mg From Glucagon-Like Peptide-1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment Endocrine Practice. PMID 38723893
  3. [3] Eli Lilly and Company (2026). Zepbound prescribing information DailyMed, U.S. National Library of Medicine. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence